The market for high functioning antibodies used in therapeutics, diagnostics, or research has grown
considerably in the past two decades. The advent of high throughput display technologies has helped fuel this growth. Like peptide and enzyme engineering, antibody engineering has taken two paths; one towards directed evolution techniques and the other towards rationally designed libraries. The Gen9 BioFab® process has solutions for both of these antibody engineering strategies:
- Our high diversity variant library product allows researchers to screen highly diverse gene libraries to find that needle in the haystack.
- Small rationally designed antibody libraries provide a means for focused, algorithm based selection of functional antibodies. These can be ordered as DNA variant libraries or as custom gene synthesis products.
The award winning Gen9 BioFab allows customers to inexpensively test and refine millions of enzyme designs to select high value products.